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Summary 
A host's ability to resist certain pathogens such as Leishmania major can depend upon the phenotype 
of T  helper  (Th) subset that develops. Different murine genetic backgrounds are known to 
significantly alter the direction of Th subset development,  although the cellular basis of this 
influence is poorly understood.  To examine the basis of this effect we used an in vitro od3-T 
cell receptor (TCR) transgenic system for analysis of Th phenotype development.  To control 
for TCR. usage, we derived the DOl1.10 c~/3-TCR transgene in several genetic backgrounds. 
Our findings suggest that the effects of genetic background on Th phenotype development reside 
within the T cell, and not the antigen-presenting  cell compartment. Transgenic T cells from 
both the B10.D2 and BALB/c backgrounds showed development toward either the Thl or Th2 
phenotype under the strong directing influence of interleukin (IL) 12 and IL-4,  respectively. 
However, when T  cells were activated in vitro under neutral conditions in which exogenous 
cytokines were not added, B10.D2-derived T cells acquired a significantly stronger Thl phenotype 
than T cells from the BALB/c background, correspondent with in vivo Th responses to Leishmania 
in these strains. Importantly, these cytokine differences resulted in distinct functional properties, 
because B10.D2- but not BALB/c-derived T cells could induce macrophage production of nitric 
oxide, an important antimicrobial factor. Thus, the genetically determined default Th phenotype 
development observed in vitro may correspond  to in vivo Th subset responses for pathogens 
such as Leishmania  which do not initiate  strong Th phenotype-directing signals. 
S 
ubsets  of CD4 §  Th cells regulate the effector mecha- 
msms of the immune response through the production 
of distinct patterns of cytokines (1-3). The subset of T cells 
termed Thl  cells, which produce IL-2,  IFN-%  and lym- 
photoxin, are important for immunity against viral and in- 
tracellular pathogens, such as Leishmania major (1-5). In con- 
trast, Th2 cells produce IL-4, IL-5, IL-10, and IL-13, which 
contribute either to  the direct  enhancement of humoral- 
mediated immunity or to the suppression of cell-mediated 
immunity (1-5).  Thus, by directly regulating the effector 
mechanisms  that  evolve during  an  immune response-to 
pathogen, these distinct Th subsets can have a profound im- 
pact  on  the  host's  resistance or susceptibility  to  distinct 
pathogens  (4,  5). 
One of the best characterized examples of the association 
between the Th subset of the immune response and the host's 
resistance to a pathogen is routine experimental Leishmani- 
asis (6-9). In this model, susceptibility is associated with the 
development of a Th2-dominated immune response, whereas 
Thl-dominated responses resolve the infection. Susceptibility 
to Leishmania  is not due to the absence of precursor cells of 
either Th subset, since several  immunological manipulations 
can redirect the genetically determined Th subset develop- 
ment (10-17). Strikingly, such immunological manipulations 
must be carried out within the first week after infection (11, 
18). Thus, the period early after Leishmania infection appears 
critical for the establishment of either a curative Thl or an 
exacerbating Th2 response. 
Many recent in vivo and in vitro studies have indicated 
that cytokines present during early T cell activation by an- 
tigen can profoundly influence the direction of Th pheno- 
type development (11-13, 18-27). It has been suggested that 
genetic differences  in the regulation of these cytokine-mediated 
mechanisms  may determine resistance  or susceptibility  to Le/sh- 
man/a (11). However, a recent study by Reiner et al. (28) found 
little differences in the mR.NA levels of cytokines produced 
within the first 4 d during infection of genetically suscep- 
tible BALB/c or resistant C57BL/6 mice. In particular, the 
production of IL-4 and IL-12, which are the dominant in- 
ducers of Th2 and Thl development, respectively (10-12, 19, 
20, 22-26),  was not significantly different during this crit- 
ical early period of Th phenotype development. Whereas other 
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genetic basis for susceptibility to L. major is largely still un- 
resolved. 
We have previously employed a murine a/~-TCR trans- 
genic system to examine the regulation of Thl and Th2 pheno- 
type development (22). This in vitro TCR transgenic model 
allows manipulation and early examination of developmental 
events under well-defined conditions of APCs, cytokines, and 
exposure to pathogens. Using this system, we recently demon- 
strated that certain bacteria can elicit Thl responses  by in- 
ducing macrophage production of IL-12 (24, 30, 31). Thus, 
this TCR transgenic model might be useful for the study 
of the genetic basis of Leishmania susceptibility since we can 
easily manipulate the genetic background of either the APC 
or the responding T  cell. By defining the cellular locus of 
the genetic susceptibility, we may facilitate definition of the 
molecular basis  of this difference. 
In this report, we find that L.  major promastigotes have 
little effect on Th phenotype development in our transgenic 
model, regardless of the genetic background of the APC popu- 
lation (susceptible BALB/c, or resistant B10.D2 [6]).  Since 
Leishmania promastigotes fail to provide a strong stimulus 
for driving Th phenotype development to either extreme 
phenotype, genetic factors affecting the default development 
ofT cells may be responsible for strain differences in Th subset 
development during Leishmania infection. By breeding the 
DO-11.10 c~/~-TCR transgenes into the BALB/c and B10.D2 
backgrounds, we have been able to directly compare the in- 
trinsic tendencies of T cells from both genetic backgrounds 
to develop toward either Thl or Th2 cells. Our findings sup- 
port a model in which the genetic susceptibility resides not 
in differential responses ofAPCs (macrophages) towards the 
Leishmania pathogen, but rather one in which the intrinsic 
capacity of T  cells to develop  towards the Th2 phenotype 
is  amplified in the BALB/c background in the absence  of 
pathogen-driven signals. 
Materials and Methods 
Animals.  Mice  transgenic for DOl1.10 cr  (32) were 
selected by staining peripheral blood leukocytes  with the anticlono- 
type mAb KJ1-26 (33). TCR transgenics on the BALB/c back- 
ground have been backcrossed for six to eight generations. TCR 
transgenics used in these experiments were bred to the B10.D2 or 
DBA/2J background for two to four or two to three generations. 
4-6-wk-old  female mice were purchased from Harlan  Sprague 
Dawley (Indianapolis, IN) (BALB/c), or The Jackson Laboratory 
(Bar Harbor, ME) (BALB/cByJ, B10.D2/nSnJ, and DBA/2J). 
Tissue Culture Media.  Cultures  were maintained in  Iscove's 
modified Dulbecco's Eagle medium (GIBCO BRL, Gaithersburg, 
MD) supplemented with 10% FCS (Hyclone, Logan, UT), 2 mM 
L-glutamine,  0.1 mM sodium pyruvate,  0.1 mM MEM nonessential 
amino acids, 100 U/ml peninciUin, 100/zg/ml streptomycin  (GIBCO 
BRL), and 50 #M 2-ME (Sigma Chemical Co., St. Louis, MO). 
mAbs, Cytokines, and Reagents.  The anti-IL-4 mAb 11Bll has 
been previously described (34). Recombinant Ib4 was obtained at 
DNAX. Recombinant 1I.-12 was the gift of Dr. S. F. Wolf(Genetic 
Institute, Cambridge, MA). Heat-killed Listeria monocytogenes was 
the gift of Dr. E. R. Unanue (Washington University School of 
Medicine) (35). Live or heat-killed L. major was the gift of Dr. 
D. G. Russell (Washington University School of Medicine). The 
antigenic peptide OVA 323-339 (32) was synthesized  on a Applied 
Biosystems model 430 peptide synthesizer (model 430; Applied 
Biosystems, Foster City, CA). 
Flow Cytometry Reagents.  Anti-CD28 was provided  by Dr. J. p. 
Allison  (University  of California,  Berkeley, CA)  (36). Goat 
anti-hamster-FITC was purchased from The Jackson Laboratory. 
Anti-CD4-FITC  and anti-MeM4-PE were obtained from Phar- 
Mingen (San Diego, CA). The anticlonotypic Ab KJf-26 has been 
described (33). Streptavidin-PE was purchased from Southern Bio- 
technology Associates (Birmingham, AL). 
Transgenic T Cell Purification.  CD4 + T cells from transgene- 
positive mice were purified by flow cytometry sorting when noted 
(see next section) or as described below. Briefly,  cells from periph- 
eral lymph nodes (cervical, axial, brachial, and inguinal) were: (a) 
depleted of class II- or CDS-bearing cells using the pan anti-class 
II mAb CA4 (a gift of  Dr. A. L. Glasebrook, Eli Lily, Indianapolis, 
IN) and the anti-CD8 mAb 3.155 (37) with rabbit complement 
(Cedarlane, Hornby, ONT,  Canada); (b) depleted of slg + cells 
using sheep anti-mouse IgG magnetic beads (Dynal, Lake  Success, 
NY); (c) isolated on a density gradient (Histopaque-1119; Sigma 
Chemical Co.); and (d) depleted of plastic adherence  cells by incu- 
bation at 37~  for 2-4 h. The purified T cells were routinely 95% 
CD4 § and 80% KJ1-26  + by flow  cytometry analysis  and failed  to 
proliferate or produce cytokines when cultured with OVA peptide 
in the absence of added APC. CD4 +, KJ1-26  § T cells from unim- 
munized mice appeared phenotypically naive via several criteria, 
including Pgp-1  I~ (22), and MeM4  hi expression (our unpublished 
data). No differences  have been observed between T cells purified 
from spleen versus peripheral lymph nodes. 
Flow Cytometric Purification of CD4 + T Cells.  T cells were par- 
tially purified from spleens by complement lysis  of CA4 (anti-class 
II) and 3.155 (anti-CD8) stained cells. After isolation on a density 
gradient  (Histopaque-1119), T  cells were stained with FITC- 
conjugated anti-CD4 mAb, and PE-conjugated anti-MeM4 mAb 
(PharMingen), and sorted on a Flow cytometer (Epics 757; Coulter, 
Hialeah, FL) to achieve  purities of ~98% MeM4 § CD4 § T cells. 
mAb staining had no effect on the function of T cells. 
T Cell Culture.  T cells (2.5  x  10S/well) were stimulated in 
2-ml cultures in 24-well plates with 0.3/~M OVA peptide presented 
by irradiated BALB/c or B10.D2 splenocytes (2,600 tad,  5  x 
106/well). Supernatants were collected at 48 h and cells were ex- 
panded threefold into fresh medium at 72 h. On day 7, the T cells 
were harvested, washed, counted,  and  restimulated at  2.5  x 
10Vwell by 5 x  106 BALB/c splenocytes  presenting 0.3 #M OVA 
peptide without added experimental conditions in order to deter- 
mine the resulting Th cell phenotype. Supernatants were collected 
at 24 or 48 h and the eytokine profile of the T cell line was assayed 
by ELISA. 
Experiments using sorted T cells were similar, except initial T 
cell numbers were lower (105). Thus, cultures were not expanded 
on day 3. Other aspects were identical, including  restimulation  con- 
ditions. 
Nitrite Production Assay.  4-d thioglycolate-elicited  peritoneal ex- 
udate cells (PECs) were adhered at 10S/well in 96-well plates for 
more than 4 h. After nonadherent cells were removed by washing 
(twice), T cells were added at indicated concentrations with 0.3 
#M OVA peptide. Nitrite production  was assessed  at 36 h by reading 
the As4o of the mixture of 100/zl of cell-free supernatant with an 
equal volume of the Griess reagent (38). 
Cytokine Assays.  Quantitation  of IL-2, IL-4, and IFN-% was 
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dards for ELISA were calibrated to cytokines purchased from Gen- 
zyme (Cambridge, MA). fiN-3' standards were the kind gift of 
Dr. R. D. Schreiber (Washington University School of Medicine). 
Results and Discussion 
APCs from B10.D2 and BALB/c Mice Do Not Differ in Their 
Response to Leishmania major.  Our previous studies using the 
ot/3-TCR transgenic system demonstrated that the induc- 
tion of Thl development in OVA-specific T cells by Listeria 
monocytogenes is largely driven by macrophage production of 
IL-12 (24, 30, 39). We therefore asked whether Thl responses 
to L. major in resistant strains might also be mediated by mac- 
rophage IL-12 production, and whether deficiencies in this 
pathway could explain Th2 responses  to Leishmania in sus- 
ceptible strains  (10). In these experiments, we used APCs 
from BALB/c or B10.D2 backgrounds for presentation of OVA 
to ot/~-TCR transgenic T ceils. These particular strains rep- 
resent both Leishmania-resistant  (B10.D2)  and -susceptible 
(BALB/c)  backgrounds which express I-A  d, the restricting 
dement for the DOl1.10 ot/~-TCR. Addition of heat-killed 
Listeria induced Thl development when H-2  d splenic APCs 
from either BALB/c or B10.D2 mice were used for primary 
activation of transgenic T cells (Fig.  1). In contrast, live or 
heat-killed L. major promastigotes failed to induce Thl de- 
velopment regardless of the genetic background of the APCs 
used (Fig. 1). Heat-killed L. major at high concentrations (5  x 
106/well)  slightly reduced the level  of IFN-7  production 
seen upon in vitro restimulation at day 7, although these re- 
sponses  were similar for APCs of both strains  (Fig.  1). 
The data for in vivo IL-12 expression  during Leishmani- 
asis is controversial. Some have argued that IL-12 can be in- 
duced early during infection of some, but not all, resistant 
mouse strains,  as reflected in the NK activity (29).  In con- 
trast, our data are consistent with another report that IL-12 
is not produced by macrophages in response  to Leishmania 
promastigotes in vitro, and that IL-12 p40 mRNA is not 
upregulated early during infection in vivo (28).  Thus, the 
genetic basis of Thl development observed  during in vivo 
Leishmania infection in these resistant strains may not result 
from the early enhanced production of IL-12 by macrophages. 
In the absence of the strong Thl-directing influences of IL- 
12 (Fig.  1), the factors most critical for determining genetic 
susceptibility to Leishmania would be those governing T cell 
development at neutral or default conditions. 
One possibility was that the APCs from resistant strains 
might inherently favor Thl phenotype development. How- 
ever, the intrinsic capacity ofB10.D2 APCs to direct Th pheno- 
type development in vitro (Fig.  1) is not distinct from that 
of BALB/c APCs and thus cannot account for the enhanced 
Thl development in the B10.D2  strain observed  during in 
vivo responses  to Leishmania  (6). 
Transgenic T  Cells from BIO.D2 Mice Preferentially Develop 
under Neutral Conditions toward the Thl Phenotype in Compar- 
ison to BALB/c T  Cells.  To directly test whether inherent 
T cell differences between these strains could account for varied 
Th phenotype development, we crossed the DOll.10 c~//~- 
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Figure 1.  L. majorpromastigotes  do not induce  Thl development.  2.5 x 
10  s purified CD4 + lymph node T cells from unimmunized  transgenic 
mice were stimulated  by 5 x  106 irradiated  BALB/c  or B10.D2 spleno- 
cytes presenting OVA-peptide (0.3/~M) in the presence of the indicated 
condition. As described  in Materials  and Methods,  T cells were harvested 
on day 7, washed, and counted. 2.5 x 10  s T cells were restimulated  with 
BALB/c splenocytes  and OVA-peptide without other additions to assess 
the effects  of the indicated  condition  on Th phenotype.  Supernatants  were 
harvested  at 48 h and assayed  for IL-4  and IFN-3'  by ELISA.  Experimental 
conditions included addition of 5 x  106 or 1.7  x  106/well heat-killed 
L. major  promastigotes (HK L. major), or addition  of 1.7 x 106/well  live 
L. major promastigotes (Live L. major). Experimental  controls included 
no additions  (-), addition  of 200 U/m1 IL-4 (Ib4), or addition  of 20  x 
106/weU heat-killed L.  monocytogenes (HK Listeria monocytogenes). Sta- 
tionary  phase  L. major  promastigotes  were heat  killed  at 65~  for 15 rain. 
TCR transgene into these genetic backgrounds to provide 
for uniform TCR use in naive CD4 § T  cells. Because the 
DOl1.10 a/~-TCR is positively selected by I-A  d, we spe- 
cifically bred to Leishmania-susceptible (BALB/c) and -resistant 
(B10.D2) strains of the H-2  d haplotype. Since the H-2  d locus 
in the B10.D2 strain was derived from the DBA/2J strain, 
we also bred the TCR transgene into the DBA/2J strain as 
a control. 
Because positive selection is dependent not only on the 
particular MHC molecule, but also upon self peptides pre- 
sented by the MHC, it was important to demonstrate that 
selection and peripheral maturation of transgenic T cells oc- 
curred similarly in each of these genetic backgrounds. Fur- 
thermore, because alterations in the level of surface markers 
can influence T  cell responsiveness  (40,  41), we also exam- 
ined the levels of surface markers such as CD28 and CD4. 
We found that levels of KJ1-26 TCR clonotype, CD4, and 
CD8, are identical on T cells from ol/~-TCR transgenic mice 
bred to either the BALB/c (Fig. 2, a-c), B10.D2 (Fig. 2, d-J), 
or DBA/2J background (data not shown). 
Transgenic T cells from the BALB/c, B10.D2, or DBA/2J 
backgrounds were activated in vitro under identical condi- 
tions without addition of exogenous factors for 7 d. When 
restimulated under identical conditions, transgenic T  cells 
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Figure 2.  Genetic background 
does not alter  expression  of CD28, 
TCR, and CD4 on T cells. T cells 
from DOl1.10 ~x/B-TCR trans- 
genic mice backcrossed to  the 
BALB/c or B10.D2 backgrounds 
(third generation)  were stained  ei- 
ther with (1) biotinylated  KJ1-26 
(anti-DOll.10 ~//~-TCR)  followed 
by streptavidin-PE  (A and D), (2) 
FITC labeled  anti-CD4 (B and E), 
or (3) anti-CD28  followed  by FITC 
goat anti-hamster Ig (C and F). 
Cells were then analyzed on  a 
FACScan  |  (Beeton Dickinson). 
derived from BALB/c mice reproducibly generated approxi- 
mately two- to threefold less IFN-y and three- to fivefold 
greater levels of IL-4 than T  cells derived from the B10.D2 
background (Fig. 3 a, Table 1). These differences in cytokine 
profile were also evident in the tertiary stimulations ofT cells 
(data not shown), suggesting that these are stable properties 
of phenotype acquisition.  However, the  strain-dependent 
skewing of IL-4 and IFN-3~ production was not evident at 
48 h during the primary stimulation (Table 2),  suggesting 
that freshly isolated B10.D2 T  cells are not already of the 
:Fhl phenotype. Instead, these data suggest a predisposition 
for B10.D2 T cells to develop toward the Thl phenotype under 
neutral or default in vitro conditions, in comparison with 
BALB/c T  cells. 
We also carried out an experiment in which T cells from 
both backgrounds were primed using APCs from each back- 
ground. BALB/c-derived T cells, when primed as described 
in Table 1 with OVA and BALB/c splenocytes, produced 12.6 
U/ml IFN-3' and 91  U/ml IL-4,  and when primed with 
B10.D2 splenocytes, produced 9.4 U/ml IFN-'y and 90 U/ml 
IL-4, similar to results in Fig.  1.  In contrast, T  cells from 
a  third generation B10.D2  backcross,  when primed with 
BALB/c splenocytes,  produced 482  U/ml  IFN-3'  and <5 
U/ml IL-4, and when primed with B10.D2 splenocytes, pro- 
duced 666  U/ml IFN-3~ and <5 U/ml IL-4. These results 
confirm our earlier conclusion that the difference between 
these two backgrounds for Th phenotype resides within the 
T  cell rather than within the APC (Fig.  1). 
Furthermore, these strain-dependent phenomena did not 
appear to be due to dramatic differences in primary T  cell 
activation between BALB/c and B10.D2 T  cells, or due to 
contaminating memory cells in the CD4 + T  cell prepara- 
tions.  Experiments using populations of naive (Mel-14 ~i) 
CD4 § T  cells showed similar results as experiments using 
unseparated CD4 + T  cells (Table 1).  There was no differ- 
ence in the levels of T cell proliferation between strains during 
the primary stimulation (assessed between 48 and 72 h, data 
not shown). However, recoveries from primary cultures of 
B10.D2 T  cells were typically somewhat lower (mean 1.8- 
fold; range 1.1-3.7;  n  =  7) than recoveries from cultures of 
BALB/c T cells. Lastly, T cell production of IL-4 and IFN-y 
was similar  for BALB/c- or B10.D2-derived  T  cells during 
the primary stimulation (Table 2). It is unclear whether the 
differences in primary IL-2 or IL-4 levels (Table 2) could con- 
tribute toward the Th phenotype skewing observed, although 
it has been reported that these cytokines are important for 
the development of IL-4-producing cells (19). 
Whereas the DOl1.10 TCR has been maintained on the 
BALB/c background for approximately eight generations, the 
crosses to the B10.D2  and DBA/2J backgrounds have been 
carried out for only four generations. Several lines of  evidence 
suggested that absolute genetic purity was not needed to ob- 
A  B 
BALB/c  B 10.D2  BALB/c  DBA/2J 
T  cell  background 
Figure 3.  Bt0.D2 T cell preferentially  default to the Thl phenotype, 
in comparison  with BALB/c  T cells. Purified  lymph  node CD4 + T cells 
were cultured  as described  in Fig. 1 in the absence of experimental  condi- 
tions to assess the effects  of genetic  background  on default  Th phenotype 
development  comparing  (A) BALB/c  and B10.D2 T cells, or (B) BALB/c 
and DBA/2J T cells. T cells were stimulated  with BALB/c  splenocytes 
and OVA-peptide. Data shown  are the average  from (/1) five  experiments 
or (B) three experiments, _+ SE, using  second and third generation  back- 
crossed animals. Cytokine  production  during the secondary  stimulation 
was assayed  at 24 instead of 48 h since differences  in proliferation  due to 
genetic background may affect  late cytokine  levels. 
716  Genetic  Background Effects on Th Phenotype  Development Table  1.  Effects of Backcrossing the BALB/c  TCR  Transgenic to BIO.D2 on  T  Cell Cytokine Production 
during the Secondary Stimulation 
Expt.  No. 
Cytokine production* 
T  cell background 
Experimental 
crosses to B10.D2 
Type of cross to B10.D2  IL-4  IFN-'y  IL-4  IFN-)' 
Ratio of BALB/c 
control over B10.D2 
backcross 
BALB/c control  Cytokine 
IL-4  IFN-3, 
1  (BALB/c  x  B10.D2)F1  61.4  60.9  134.7  25.6 
2*  14.2  82.9  42.5  34.5 
1  F1  ￿  B10.D2  8.3  82.1  57.9  17.6 
2  15.5  102.9  65.8  61.6 
3  17.5  54.0  22.6  63.8 
4S  9.1  514.1  61.7  190.7 
5  S  18.1  229.6  63.2  172.9 
1  (F1  x  B10.D2)  x  B10.D2  (5.0  50.2  53.6  13.6 
2  9.5  165.3  38.7  40.8 
2.2  0.46 
3.0  0.33 
7.0  0.14 
4.2  0.60 
1.3  0.85 
6.8  0.37 
3.5  0.75 
>10.0  0.27 
4.1  0.25 
* Experiments were performed as described in Fig. 3.  Cytokine levels were assayed on 24-h supernatants. 
* T cells were FACS sorted for CD4 + Mel-14  hi expression. 
S 48-h supernatants. 
serve significant effects of genetic background on Th pheno- 
type development. First, the effect of the B10.D2 background 
on the enhanced Thl development seen in Fig. 3 was evident 
even in  the  initial (BALB/c  x  B10.D2)F1  cross (Table  1). 
Furthermore, additional backcrosses to the B10.D2 strain (up 
to four) did not produce qualitatively different results. This 
finding is consistent with the dominant or codominant re- 
sistance shown against Leiskmania  in vivo (6, 42), although 
Table  2.  Cytokine  Production by DOll.lO  oJfl-TCR  T  Cells from Different Genetic Backgrounds during the Primary Stimulation 
Cytokine production* 
Ratio of 
(U/ml  _+  SE)  BALB/c over B10.D2 
Cytokine assayed  T  cell background  48  72  48  72 
h  h 
IL-4*  BALB/c  3.7  +  0.9  7.5  -+  1.3  1.0  1.7 
B10.D2  3.5  -+  1.0  4.3  -+  1.4 
IFN-'y  BALB/c  16.3  +-  4.7  32.0  -+  11.2  0.7  0.8 
BIO.D2  23.8  -+  6.0  38.3  -+  5.6 
IL-2  BALB/c  180.1  +  14.8  149.0  +-  35.6  1.8  2.7 
B10.D2  95.8  •  16.4  55.8  +  23.5 
* Average of at least five experiments as described in Fig. 3.24-h cytokine levels for IFN-'y is extremely low (<4 U/ml) and for IL-4 is undetectable 
I 
IL-4 <0.8-1.5 U/ml), in contrast with 24-h supernatants after secondary stimulation. 
These levels are low and near the limit of detection (0.8-1.5  U/ml). 
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a single or multiple genes. Second, the effect of the B10.D2 
genetic background for enhancing Thl  development  was 
specific since this effect was not seen when the od~/-TCR 
transgene was bred for up to three generations to the DBA/2J 
genetic background. In fact, DBA/2J appeared to generate 
T cells under neutral conditions with an even greater Th2- 
like phenotype than the BALB/c background (Fig. 3 b). Thus, 
even though B10.D2  and DBA/2J share the H-2  d MHC 
locus, the influence on Th phenotype development clearly 
segregated from the MHC. Similarly, resistance to Leishmania 
is not MHC dependent (6). Third, we have examined cytokine 
production of nontransgenic T cells purified from BALB/c 
or B10.D2 mice using Con A as a polyclonal activator. Con- 
sistent with our data using TCR transgenic  mice, T  cells 
from genetically pure B10.D2 mice similarly produced more 
IFN-7 and less IL-4 than T cells from BALB/c mice after 
restimulation (data not shown). 
The differences in default Th development  observed for 
T cells derived from BALB/c or B10.D2 mice did not, how- 
ever, represent a general defect in either Thl or Th2 develop- 
ment in these strains. T cells derived from either background 
developed into strong Thl cells when IL-4 was neutralized 
and IL-12 was added in primary cultures (Fig. 4). Further- 
more, the addition of IL-4 in primary cultures  greatly in- 
hibited IFN-3'  production and enhanced IL-4  production 
during restimulation ofT cells from both BALB/c and B10.D2 
strains. Thus, the previously described IL-12/IL-4 regulation 
of Thl and Th2 phenotype appeared to operate similarly in 
both genetic backgrounds.  Once again, a significant differ- 
ence in Th phenotype development was observed between 
these two genetic backgrounds when T cells are activated 
under neutral conditions (Fig. 4). 
BIO.D2 but Not BALB/c T Cells Developing under Neutral 
Conditions Are Capable of  Inducing Nitric Oxide  We have con- 
sistently observed two- to threefold differences in IL-4 and 
IFN-y production between T cells derived from BALB/c or 
B10.D2 mice (Table 1). However, the levels of cytokines pro- 
duced under the default developmental pathway are low in 
comparison with T cells driven toward the Thl or Th2 pheno- 
type with exogenous cytokines (Fig. 4). It was therefore im- 
portant to determine whether these cytokine differences  rep- 
resent  significant  changes in the helper function of these 
CD4 + T cells. We chose to examine the capacity of T cells 
derived from either the BALB/c or B10.D2 background to 
promote macrophage production of nitric oxide (NO)  z, crit- 
ical for the killing  of many pathogens,  including L.  major 
(43, 44).  NO production is dependent on the presence of 
the Thl cytokine IFN-3,, and is inhibited by the Th2 cytokines 
IL-4 and IL-10 (45). 
Strikingly, only the T cells of the B10.D2 background pre- 
viously activated  under neutral conditions in vitro could 
strongly promote NO production by macrophages, whereas 
T cells of the BALB/c background induced only minimal levels 
1 Abbreviation  used in this paper:  NO, nitric oxide. 
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Both B10.D2 and BALB/c T cells  respond to exogenous  factors 
affecting Th development. T cells were cultured as described in Fig. 3. 
Experimental conditions included addition of ID4 (200 U/ml) to induce 
Th2 development, no additions (-), or addition of 10 #g/ml 11Bll (anti- 
ID4) and I1.-12 (10 U/ml) to induce Thl development. Data shown are 
representative of greater than four experiments. 
of NO production (Fig. 5). This inability of BALB/c-derived 
T cells to promote NO production is not an intrinsic defect, 
because T cells from either BALB/c or B10.D2 mice induced 
to acquire the Thl phenotype by IL-12 and anti-IL-4 could 
induce NO production (Fig. 5). In contrast,  Th2 cells from 
either strain, generated by activation in the presence of IL-4, 
were poor inducers of NO (Fig. 5). Thus, the differences in 
default Th phenotype development due to the background 
of the T cell (BALB/c or B10.D2) resulted in dramatic differ- 
ences in the activation  of a critical  macrophage  effector  function. 
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Figure  5.  B10.D2 T cells cultured under default conditions efficiently 
induce NO production in comparison to BALB/c T cells. T cells cultured 
in the absence of experimental conditions derived from Fig. 3 were used 
to stimulate NO production from peritoneal exudate cells (FECs) as de- 
scribed in Materials and Methods. As controls, T cells of the Th2 or Tht 
phenotype were also assayed. Th2 cells were derived by addition of IL4 
(100 U/ml) during the primary culture, and Thl cells were induced by 
the addition of 10/zg/ml 11Bll (anti-IL-4)  with 5 U/ml I.b12 (Ib-12). The 
experiment  shown is representative of three experiments. 
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cell can profoundly alter the default pathway of Th pheno- 
type development may explain certain differences between 
previous data from our laboratory and others. For example, 
we had found that T cells stimulated under neutral condi- 
tions developed into an IL-4-producing, Th0 population, 
which consistently  showed significant effects o~anti-IL-10 
and  anti-IL-4  antibodies  (22). However,  others,  using  a 
different TCR transgenic system maintained on the B10.A 
background, found little effects of anti-IL-4 and anti-IL-10 
on Th phenotype development, and suggested that Thl de- 
velopment might represent a default pathway (23). Our present 
findings may explain this discrepancy. We find that T cells 
from the B10 background when activated under neutral con- 
ditions develop a more Thl-like phenotype and might be ex- 
pected to show quantitatively smaller effects of neutralizing 
IL-4 or IL-10. 
Our findings taken together with previous studies on Th 
phenotype development and Leishmania susceptibility sug- 
gest a model for strain-dependent Th phenotype development. 
Early in vivo immune responses to Leishmania occur in the 
absence of strong macrophage activation (28), a condition 
that might correspond  to the default pathway we observe 
in vitro. In the absence of strong pathogen-driven signals, 
strain differences  in this default developmental  pathway would 
have a large influence on the resulting Th phenotype of the 
immune response. 
During later stages of Leishmaniasis, IL-12 expression is 
induced by the amastigote form of Leishmania (28, 29). In 
BALB/c mice, this late IL-12 production is ineffective  at driving 
T  cell responses to a Thl phenotype since by that time T 
cells have acquired the Th2 (IL-4 producing) phenotype and 
may be resistant to the effects of IL-12. We have previously 
found that the effects of IL-4 on Th phenotype can dominate 
the effects  of IL-12 for Th phenotype development (24). Also, 
others have shown that Th2 cells derived from transgenic 
mice in vitro cannot be induced to acquire Thl specificity 
by IL-12 (Perez, V. C., J. Lederer, A. Lichtman, and A. K. 
Abbas, manuscript in preparation).  In resistant mice, how- 
ever, Thl-like cells generated by default during the early period 
of infection, would not produce su~cient amounts of IL-4 
to block the effects of IL-12. In this case, amastigote-induced 
IL-12 could augment IFN-3' production (46, 47) and the sub- 
sequent development  of a strong Thl phenotype. 
The regulation of default Th phenotype development may 
also be important in other disease processes. For example, 
Scott et al. (48) have recently showed that BALB/c mice are 
resistant to diabetes in a transgenic model, whereas B10.D2 
mice are susceptible. Also, BALB/K mice generate effective 
Th2-type responses to the helminth Trichuris muris, whereas 
B10.BR mice generate ineffective  Thl responses (49). In both 
of these disease models, the self antigen or pathogen may 
fail to generate strong cytokine signals to direct Th develop- 
ment, so that the default pathways of T  cell development 
may determine disease outcome. 
In vitro analysis of default Th phenotype development, 
however, may not always be predictive of disease outcome. 
For example, on the basis of in vitro Th phenotype develop- 
ment (Fig. 3), DBA/2J mice would be expected to be more 
susceptible to L. major than BALB/c mice because the T cells 
develop more of a Th2-character. Rather, DBA/2J mice are 
less susceptible (50). However, our observation that DBA/2J 
T  cells develop to a more Th2-1ike phenotype than either 
BALB/c or B10.D2 T cells may relate to the fact that DBA/2J 
clear Leishmania distinctly less well than resistant mice such 
as B10.D2 (50). This suggests that there are other genetic 
factors which determine resistance to Leishmania in addition 
to those affecting default Th phenotype development. 
Moreover, the factors controlling susceptibility may differ 
between pathogens. For example, genetic susceptibility  to Can- 
dida correlates well with our findings regarding in vitro Th 
phenotype responses. Effective immunity to Candicla is Thl 
dependent (51). As our results would predict, DBA/2J mice 
are more susceptible to Candida than BALB/c and C57/BL6 
mice (51). Thus, the effects of genetic background on default 
in vitro Th phenotype development may contribute to our 
understanding in vivo Th subset responses to some pathogens. 
Since the host-pathogen relationship is complex and likely 
to be affected by many genes, the relative importance of de- 
fault Th phenotype development in any specific  in vivo situ- 
ation cannot be absolutely determined. 
In summary, we have demonstrated a genetic difference 
between T cells of the BALB/c versus B10.D2 background 
in their default in vitro Th phenotype development which 
could relate to in vivo Th responses. Genetic differences do 
not appear to reside within the resident splenic APC popula- 
tions studied. These differences in default Th phenotype de- 
velopment result in significant differences in both cytokine 
profiles and most notably Th activity for macrophage induc- 
tion of NO. Thus, this in vitro system may be useful for 
addressing the molecular and genetic basis for these strain 
differences. 
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